Form DEFS14A - Definitive proxy statement for special meeting:
SEC Accession No. 0000950123-01-503024
Filing Date
2001-05-29
Accepted
2001-05-29 00:00:00
Documents
1
Period of Report
2001-06-20

Document Format Files

Seq Description Document Type Size
1 OSI PHARMACEUTICAL, INC. y49193sdefs14a.txt DEFS14A 25772
  Complete submission text file 0000950123-01-503024.txt   27348
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: DEFS14A | Act: 34 | File No.: 000-15190 | Film No.: 1649098
SIC: 2835 In Vitro & In Vivo Diagnostic Substances